In order to determine the clinical relevance of ACSL/SCD network activation in CRC, we analyzed the putative association between the simultaneous overexpression of ACSL1, ACLS4 and SCD with clinical outcome in a set of 77 samples from stage-II CRC patients. Here, SCD is linked to colorectal carcinoma.